Stereotactic Surgery Devices Market Outlook:
Stereotactic Surgery Devices Market size was valued at USD 27.89 Billion in 2025 and is set to exceed USD 41.68 Billion by 2035, expanding at over 4.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of stereotactic surgery devices is estimated at USD 28.92 Billion.
The reason behind the growth is due to the rising cases of cancer across the globe. Stereotactic radiosurgery, such as Gamma Knife, is a three-dimensional surgical technique and a very precise form of therapeutic radiation that is often used to treat noncancerous (benign), cancerous (malignant) brain tumors, and also to treat small, early-stage lung cancer and pancreatic cancer, or cancers that have spread to the lung, liver, or adrenal gland.
For instance, Cancer is one of the world's top causes of death, accounting for more than 9 million deaths in 2020, and it is anticipated that by 2040, there will be more than 27 million new cancer cases worldwide.
The growing technological advancements are believed to fuel the market growth. Stereotactic radiation is constantly being improved, owing to technological advances that aid in boosting treatment precision.
